Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
AD     Remove this Ad

SOTAC PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 10.0120.02---

What is the latest Price to Cash Earnings (PCE) ratio of SOTAC PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of SOTAC PHARMACEUTICALS is 10.01 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202510.01
Mar202420.02
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of SOTAC PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 10.01
-50.00
Mar2024 20.02
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹119.9 Cr -2.3% -12.3% -10.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,713.0 Cr -1.4% -3.2% -0.5% Stock Analytics
DIVIS LABORATORIES ₹156,811.0 Cr -1.9% -8.7% 1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,052.0 Cr -3.5% -6.6% 30.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,927.0 Cr -4% -8.3% 6.3% Stock Analytics
CIPLA ₹96,602.7 Cr -1.9% -11.9% -19% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-2.3%

-12.3%

-10.5%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses